Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells
- 26 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (11), 2259-2272
- https://doi.org/10.1007/s00210-021-02139-6
Abstract
Cyclooxygenase-2 (COX-2) is expressed in a variety of human colorectal cancer cells and can contribute to carcinogenesis. This study aimed to investigate the effect of diclofenac (DCF), a selective COX-2 inhibitor, on cell adhesion molecules and apoptosis in human colon adenocarcinoma cells. Levels of homing cell adhesion molecule (H-CAM, CD44), intercellular adhesion molecule-1 (ICAM-1, CD54), vascular cell adhesion molecule-1 (VCAM-1, CD106), and epithelial cell adhesion molecule (EpCAM, CD326) were evaluated in cancer cells overexpressing (HT29) or not expressing (HCT116) COX-2. Cell viability was determined by MTT assay, COX-2 protein levels and activity were assessed by immunofluorescence and fluorometric analysis, respectively. Endogenous levels of polyunsaturated fatty acids (PUFAs) were measured by liquid chromatography-tandem mass spectrometry (LC–MS/MS) while expression of cell adhesion molecules was analyzed by flow cytometry. Annexin V–FITC/propidium iodide-labelling and fluorometric caspase-3 activity measurements were carried out to determine apoptosis. Flow cytometry analysis revealed that the percentage of CD44 and ICAM-1 staining in HCT116 cells was significantly lower compared to HT29 cells. In HT29 cells, phorbol 12-myristate 13-acetate (PMA) induced COX-2 expression and increased CD44 and ICAM-1 levels were down-regulated by diclofenac. Stimulation of COX-2 activity in HT29 cells via PMA significantly decreased diclofenac associated increase in PUFA levels. Treatment with both diclofenac and PMA significantly increased the number of apoptotic cells and caspase-3 activity in colon adenocarcinoma cells compared to control groups. In conclusion, diclofenac’s effect to retard colorectal tumor growth and metastasis occurs in COX-2 overexpressing colon cancer cells by increased apoptosis and decreased expression of CD44 and ICAM-1.Keywords
Funding Information
- Akdeniz Üniversitesi (TYL-2020-5435)
This publication has 41 references indexed in Scilit:
- LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapyLipids in Health and Disease, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunctionLipids in Health and Disease, 2010
- Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the RewardClinical Cancer Research, 2010
- Expression of standard CD44 in human colorectal carcinoma: Association with prognosisPathology International, 2009
- Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma CellsOnline Journal of Public Health Informatics, 2008
- Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)British Journal of Pharmacology, 2008
- Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endotheliumInternational Journal of Cancer, 2004
- Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44Online Journal of Public Health Informatics, 2001
- CELL ADHESION MOLECULES AND COLON CANCERAnz Journal of Surgery, 1996